litlas
Log inCreate account

Georg Maschmeyer

Active 1991–2025

80
Papers
20,083
Citations
66
h-index
79
i10-index

Citations

Citations per year for Georg Maschmeyer1992: 2 citations1994: 3 citations1995: 5 citations1996: 5 citations1997: 7 citations1998: 5 citations1999: 10 citations2000: 14 citations2001: 16 citations2002: 26 citations2003: 28 citations2004: 34 citations2005: 45 citations2006: 33 citations2007: 41 citations2008: 52 citations2009: 87 citations2010: 93 citations2011: 121 citations2012: 111 citations2013: 100 citations2014: 130 citations2015: 112 citations2016: 142 citations2017: 117 citations2018: 154 citations2019: 589 citations2020: 609 citations2021: 605 citations2022: 427 citations2023: 305 citations2024: 485 citations2025: 196 citations1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,444 citing papers, 17.8% of this breakdownGermany: 784 citing papers, 9.7% of this breakdownFrance: 525 citing papers, 6.5% of this breakdownItaly: 477 citing papers, 5.9% of this breakdownUnited Kingdom: 472 citing papers, 5.8% of this breakdownSpain: 348 citing papers, 4.3% of this breakdownChina: 347 citing papers, 4.3% of this breakdownNetherlands: 296 citing papers, 3.6% of this breakdownSwitzerland: 270 citing papers, 3.3% of this breakdownAustralia: 251 citing papers, 3.1% of this breakdownBelgium: 219 citing papers, 2.7% of this breakdownAustria: 209 citing papers, 2.6% of this breakdown
0%17.8%Other 30.4%

Institutions

Fields

  • Medicine91.6%
  • Biochemistry, Genetics and Molecular Biology3.7%
  • Immunology and Microbiology2%
  • Health Professions0.6%
  • Agricultural and Biological Sciences0.4%
  • Engineering0.4%
  • Other1.3%

Topics

  • Antifungal resistance and susceptibility13.7%
  • Fungal Infections and Studies10.2%
  • Lymphoma Diagnosis and Treatment5.1%
  • Neutropenia and Cancer Infections4.7%
  • Pneumocystis jirovecii pneumonia detection and treatment3.1%
  • Acute Myeloid Leukemia Research3%
  • Other60.2%

Coauthors

All papers

Open in search
  1. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

    Authors: Oliver A. Cornely, Ana Alastruey‐Izquierdo, Dorothee Arenz, Sharon C.‐A. Chen, Éric Dannaoui, Bruno Hochhegger, Martin Hoenigl, Henrik Elvang Jensen, Katrien Lagrou, Russell E. Lewis, Sibylle C. Mellinghoff, Mervyn Mer, Zoi Dorothea Pana, Danila Seidel, Donald C. Sheppard, Roger Wahba, Murat Akova, Alexandre Alanio, Abdullah M. S. Al‐Hatmi, Sevtap Arıkan-Akdağlı, Hamid Badali, Ronen Ben‐Ami, Alexandro Bonifáz, Stéphane Bretagne, Elio Castagnola, Methee Chayakulkeeree, Arnaldo Lopes Colombo, Dora Corzo-León, Ľuboš Drgoňa, Andreas H. Groll, Jesús Guinea, Claus Peter Heußel, Ashraf S. Ibrahim, Souha S. Kanj, Н Н Климко, Michaela Lackner, Frédéric Lamoth, Fanny Lanternier, Cornelia Lass-Floerl, Dong‐Gun Lee, Thomas Lehrnbecher, B. Lmimouni, Mihai Mareș, Georg Maschmeyer, Jacques F. Meis, Joseph Meletiadis, C. Orla Morrissey, Márcio Nucci, Rita Oladele, Livio Pagano, Alessandro C. Pasqualotto, Atul Patel, Zdeněk Ráčil, Malcolm Richardson, Emmanuel Roilides, Markus Ruhnke, Seyedmojtaba Seyedmousavi, Neeraj Sidharthan, Nina Singh, János Sinkó, Anna Skiada, Monica A. Slavin, Rajeev Soman, Brad Spellberg, William J. Steinbach, Ban Hock Tan, Andrew J. Ullmann, Jörg Janne Vehreschild, Maria J. G. T. Vehreschild, Thomas J. Walsh, P. Lewis White, Nathan P. Wiederhold, Theoklis E. Zaoutis, Arunaloke Chakrabarti - The Lancet Infectious Diseases 2019 cited by 1,756

  2. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Authors: Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly, David A. Stevens, John E. Edwards, Thierry Calandra, Peter G. Pappas, Johan Maertens, Olivier Lortholary, Carol A. Kauffman, David W. Denning, Thomas F. Patterson, Georg Maschmeyer, Jacques Billé, William E. Dismukes, Raoul Herbrecht, William Hope, Christopher C. Kibbler, Bart Jan Kullberg, Kieren A. Marr, Patricia Muñóz, Frank C. Odds, John R. Perfect, Ángela Restrepo, Markus Ruhnke, Brahm H. Segal, Jack D. Sobel, Tania C. Sorrell, Claudio Viscoli, John R. Wingard, Theoklis E. Zaoutis, John E. Bennett - Clinical Infectious Diseases 2008 cited by 4,909

  3. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

    Authors: Mathias Rummel, N. Niederle, Georg Maschmeyer, Gamal-Andre Banat, Ulrich von Grünhagen, Christoph Losem, Dorothea Kofahl-Krause, Gerhard Heil, Manfred Welslau, Christina Balser, Ulrich Kaiser, Eckhart Weidmann, Heinz Dürk, Harald Balló, Martina Stauch, Fritz Roller, Juergen Barth, Dieter Hoelzer, Axel Hinke, Wolfram Brugger - The Lancet 2013 cited by 1,494

  4. CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    Authors: Marianne Sinn, Marcus Bahra, Torsten Liersch, Klaus Gellert, Helmut Messmann, Wolf O. Bechstein, Dirk Waldschmidt, Lutz Jacobasch, Martin Wilhelm, Bettina Rau, Robert Grützmann, Arndt Weinmann, Georg Maschmeyer, Uwe Pelzer, Jens Stieler, Jana K. Striefler, Michael Ghadimi, Sven Bischoff, Bernd Dörken, Helmut Oettle, Hanno Riess - Journal of Clinical Oncology 2017 cited by 296

  5. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

    Authors: Volker Kunzmann, Jens T. Siveke, Hana Algül, Eray Goekkurt, Gabriele Margareta Siegler, Uwe M. Martens, Dirk Waldschmidt, Uwe Pelzer, Martin Fuchs, Frank Kullmann, Stefan Boeck, Thomas J. Ettrich, Swantje Held, Ralph Keller, Ingo Klein, Christoph‐Thomas Germer, H. J. Stein, Helmut Friess, Marcus Bahra, Ralf Jakobs, Ingo Hartlapp, Volker Heinemann, Elke Hennes, Udo Lindig, Thomas Geer, Michael Ståhl, M. Senkal, Thomas Südhoff, Matthias Egger, Christoph Kahl, Christina Große-Thie, Marcel Reiser, Stefan Mahlmann, Peter Fix, H. Schulz, Georg Maschmeyer, Wolfgang Blau - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 197

  6. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

    Authors: Jean Klášterský, Julien de Naurois, K. V. I. Rolston, Bernardo L. Rapoport, Georg Maschmeyer, Matti Aapro, Jørn Herrstedt - Annals of Oncology 2016 cited by 750

  7. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Authors: Alexandre Alanio, Philippe M. Hauser, Katrien Lagrou, Willem J. G. Melchers, Jannik Helweg‐Larsen, Olga Matos, Simone Cesaro, Georg Maschmeyer, Hermann Einsele, J. Peter Donnelly, Catherine Cordonnier, Johan Maertens, Stéphane Bretagne - Journal of Antimicrobial Chemotherapy 2016 cited by 409

  8. ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients

    Authors: Johan Maertens, Simone Cesaro, Georg Maschmeyer, Hermann Einsele, J. Peter Donnelly, Alexandre Alanio, Philippe M. Hauser, Katrien Lagrou, Willem J. G. Melchers, Jannik Helweg‐Larsen, Olga Matos, Stéphane Bretagne, Catherine Cordonnier - Journal of Antimicrobial Chemotherapy 2016 cited by 295

  9. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies

    Authors: Nicola Gökbuget, Michael Kneba, Thorsten Raff, Heiko Trautmann, C. R. Bartram, Renate Arnold, Rainer Fietkau, Mathias Freund, Arnold Ganser, Wolfgang Ludwig, Georg Maschmeyer, Harald Rieder, Stefan Schwartz, Hubert Serve, Eckhard Thiel, Monika Brüggemann, Dieter Hoelzer - Blood 2012 cited by 493

  10. Positron Emission Tomography–Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial

    Authors: Ulrich Dührsen, Stefan Müller, Bernd Hertenstein, Henrike Thomssen, Jörg Kotzerke, Rolf M. Mesters, Wolfgang E. Berdel, Christiane Franzius, Frank Kroschinsky, Matthias Weckesser, Dorothea Kofahl-Krause, Frank M. Bengel, Jan Dürig, Johannes Matschke, Christine Hanoun, Thorsten Pöppel, Claudia Ose, Marcus Brinkmann, Paul La Rosée, Martin Freesmeyer, A. Hertel, Heinz‐Gert Höffkes, Dirk Behringer, Gabriele Prange‐Krex, Stefan Wilop, Thomas Krohn, Jens Holzinger, Martin Grießhammer, Aristoteles Giagounidis, Aruna Raghavachar, Georg Maschmeyer, Ingo Brink, Helga Bernhard, Uwe Haberkorn, Tobias Gaska, Lars Kurch, Daniëlle M. E. van Assema, Wolfgang Hiddemann, Dieter Hoelzer, Lilli Geworski, Karl‐Heinz Jöckel, André Scherag, Andreas Bockisch, Jan Rekowski, Andreas Hüttmann, on behalf of the PETAL Trial Investigators - Journal of Clinical Oncology 2018 cited by 251

  11. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines

    Authors: Małgorzata Mikulska, Diana Averbuch, Frédéric Tissot, Catherine Cordonnier, Murat Akova, Thierry Calandra, Marcello Ceppi, Paolo Bruzzi, Claudio Viscoli, Murat Akova, Mahmoud Aljurf, Diana Averbuch, Rosemary A. Barnes, Ola Blennow, Pierre–Yves Bochud, Emilio Bouza, Stéphane Bretagne, Roger J. M. Brüggemann, Thierry Calandra, Jordi Carratalà, Simone Cesaro, Catherine Cordonnier, Oliver A. Cornely, Tina Dalianis, Rafael de la Cámara, Peter Donnelly, Ľuboš Drgoňa, Rafael F. Duarte, Hermann Einsele, Dan Engelhard, Christopher P. Fox, Corrado Girmenia, Andreas H. Groll, Dag Heldal, Jannick Helweg Larsen, Raoul Herbrecht, Hans H. Hirsch, Elisabeth Johnson, G. A. Klyasova, Minna Koskuenvo, Katrien Lagrou, Russell E. Lewis, Per Ljungman, Johan Maertens, Georg Maschmeyer, Małgorzata Mikulska, Márcio Nucci, Christophe Padoin, Livio Pagano, Antonio Pagliuca, Zdeněk Ráčil, Patricia Ribaud, Christine Rinaldo, Valérie Rizzi Puechal, Emmanuel Roilides, Christine Robin, Montserrat Rovira, Markus Rupp, Sonia P. Sanchez, Peter Schellongowski, Petr Sedlacek, János Sinkó, Monica A. Slavin, Isabella Sousa Ferreira, Jan Styczyński, Frédéric Tissot, Claudio Viscoli, Katherine N. Ward, Anne‐Therese Witschi - Journal of Infection 2017 cited by 196

  12. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

    Authors: Peter Borchmann, Helen Goergen, Carsten Kobe, Andreas Lohri, Richard Greil, Dennis A. Eichenauer, Josée M. Zijlstra, Jana Marková, Julia Meißner, Michaela Feuring‐Buske, Andreas Hüttmann, Judith Dierlamm, Martin Soekler, Hans-Joachim Beck, Wolfgang Willenbacher, Wolf-Dieter Ludwig, Thomas Pabst, Max S. Topp, Felicitas Hitz, Martin Bentz, Ulrich Keller, Dagmar Kühnhardt, Helmut Ostermann, Norbert Schmitz, Bernd Hertenstein, Walter E. Aulitzky, Georg Maschmeyer, Tom Vieler, Hans Theodor Eich, Christian Baues, Harald Stein, Michael Fuchs, Georg Kuhnert, Volker Diehl, Markus Dietlein, Andreas Engert - The Lancet 2017 cited by 386

  13. Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

    Authors: Jannik Stemler, Sibylle C. Mellinghoff, Yascha Khodamoradi, Rosanne Sprute, Annika Y. Claßen, Sonja E. Zapke, Martin Hoenigl, Robert Krause, Martin Schmidt‐Hieber, Werner Heinz, Michael Klein, Philipp Koehler, Blasius Liss, Michael Koldehoff, Christoph Buhl, Olaf Penack, Georg Maschmeyer, Enrico Schalk, Cornelia Lass‐Flörl, Meinolf Karthaus, Markus Ruhnke, Oliver A. Cornely, Daniel Teschner - Journal of Antimicrobial Chemotherapy 2023 cited by 91

  14. Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group

    Authors: Michael Fuchs, Helen Goergen, Carsten Kobe, Georg Kuhnert, Andreas Lohri, Richard Greil, Stephanie Sasse, Max S. Topp, Erhardt Schäfer, Bernd Hertenstein, Martin Soekler, Martin Vogelhuber, Josée M. Zijlstra, Ulrich Keller, Stefan W. Krause, Martin Wilhelm, Georg Maschmeyer, Julia Thiemer, Ulrich Dührsen, Julia Meißner, Andreas Viardot, Hans Theodor Eich, Christian Baues, Volker Diehl, Andreas Rosenwald, Bastian von Tresckow, Markus Dietlein, Peter Borchmann, Andreas Engert - Journal of Clinical Oncology 2019 cited by 229

  15. ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients

    Authors: Georg Maschmeyer, Jannik Helweg‐Larsen, Livio Pagano, Christine Robin, Catherine Cordonnier, Peter Schellongowski - Journal of Antimicrobial Chemotherapy 2016 cited by 220

  16. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

    Authors: Annika Y. Claßen, Larissa Henze, Marie von Lilienfeld‐Toal, Georg Maschmeyer, Michael Sandherr, Luisa Durán Graeff, Nael Alakel, Maximilian Christopeit, Stefan W. Krause, Karin Mayer, Silke Neumann, Oliver A. Cornely, Olaf Penack, Florian Weißinger, Hans‐Heinrich Wolf, Jörg Janne Vehreschild - Annals of Hematology 2021 cited by 92

  17. Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

    Authors: Andrew J. Ullmann, Martin Schmidt‐Hieber, Hartmut Bertz, Werner Heinz, Michael Kiehl, William Krüger, Sabine Mousset, Stefan Neuburger, Silke Neumann, Olaf Penack, Gerda Silling, Jörg Janne Vehreschild, Hermann Einsele, Georg Maschmeyer - Annals of Hematology 2016 cited by 211

  18. Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Authors: Maximilian Christopeit, Martin Schmidt‐Hieber, Rosanne Sprute, Dieter Buchheidt, Marcus Hentrich, Meinolf Karthaus, Olaf Penack, Markus Ruhnke, Florian Weißinger, Oliver A. Cornely, Georg Maschmeyer - Annals of Hematology 2020 cited by 87

  19. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy—final results of the larynx organ preservation trial DeLOS-II

    Authors: Andreas Dietz, Gunnar Wichmann, Thomas Kuhnt, L. Pfreundner, Rudolf Hagen, Matthias Scheich, Oliver Kölbl, Matthias Hautmann, J. Strutz, Frank Schreiber, Ulrike Bockmühl, V. Schilling, Petra Feyer, Maike de Wit, Georg Maschmeyer, Markus Jungehülsing, Ursula C. Schroeder, Barbara Wollenberg, Christian Sittel, Marc Münter, Thomas Lenarz, Jens Peter Klußmann, Orlando Guntinas‐Lichius, Claudia Rudack, Hans Theodor Eich, Thomas Foerg, Serena Preyer, Martin Westhofen, H.-J. Welkoborsky, D. Esser, Dietmar Thurnher, S. Remmert, Holger Sudhoff, Martin Görner, J. Bünzel, Volker Budach, Swantje Held, Maren Knödler, Florian Lordick, Susanne Wiegand, Klaus Vogel, Andreas Boehm, Michael Flentje, Ulrich Keilholz - Annals of Oncology 2018 cited by 83

  20. Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Authors: Markus Ruhnke, Oliver A. Cornely, Martin Schmidt‐Hieber, Nael Alakel, Boris Boell, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Werner Heinz, Marcus Hentrich, Meinolf Karthaus, Michael Koldehoff, Georg Maschmeyer, Jens Panse, Olaf Penack, Jan Schleicher, Daniel Teschner, Andrew J. Ullmann, Maria J. G. T. Vehreschild, Marie von Lilienfeld‐Toal, Florian Weißinger, Stefan Schwartz - Mycoses 2020 cited by 72

  21. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients

    Authors: Catherine Cordonnier, Simone Cesaro, Georg Maschmeyer, Hermann Einsele, J. Peter Donnelly, Alexandre Alanio, Philippe M. Hauser, Katrien Lagrou, Willem J. G. Melchers, Jannik Helweg‐Larsen, Olga Matos, Stéphane Bretagne, Johan Maertens - Journal of Antimicrobial Chemotherapy 2016 cited by 128

  22. Invasive Aspergillosis

    Authors: Georg Maschmeyer, Antje Haas, Oliver A. Cornely - Drugs 2007 cited by 367

  23. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

    Authors: Sibylle C. Mellinghoff, Jens Panse, Nael Alakel, Gerhard Behre, Dieter Buchheidt, Maximilian Christopeit, Justin Hasenkamp, Michael Kiehl, Michael Koldehoff, Stefan W. Krause, Nicola Lehners, Marie von Lilienfeld‐Toal, Annika Löhnert, Georg Maschmeyer, Daniel Teschner, Andrew J. Ullmann, Olaf Penack, Markus Ruhnke, Karin Mayer, Helmut Ostermann, H.-H. Wolf, Oliver A. Cornely - Annals of Hematology 2017 cited by 215

  24. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

    Authors: Werner Heinz, Dieter Buchheidt, Maximilian Christopeit, Marie von Lilienfeld‐Toal, Oliver A. Cornely, Hermann Einsele, Meinolf Karthaus, Hartmut Link, Rolf Mahlberg, Silke Neumann, Helmut Ostermann, Olaf Penack, Markus Ruhnke, Michael Sandherr, Xaver Schiel, Jörg Janne Vehreschild, Florian Weißinger, Georg Maschmeyer - Annals of Hematology 2017 cited by 174